HCA Healthcare (HCA)
(Delayed Data from NYSE)
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Zacks News
Here's Why You Should Hold on to Universal Health (UHS) Now
by Zacks Equity Research
Riding high on its solid segments and an impressive top line, Universal Health (UHS) holds enough potential to reap benefits for investors.
Universal Health (UHS) Q4 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results reflect improved revenues across the company's segments, partly offset by elevated costs.
Select Medical (SEM) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Select Medical's (SEM) Q4 results reflect solid performances by its Critical Illness Recovery and Rehabilitation Hospital segments.
Acadia Healthcare (ACHC) Q4 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q4 results reflect progress in its U.S business, which gained from solid volumes, and its solid cost-management policy.
Universal Health (UHS) to Report Q4 Results: What to Expect?
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results are likely to reflect gain from better revenues.
MEDNAX's (MD) Q4 Earnings Fall Shy of Estimates, Tumble Y/Y
by Zacks Equity Research
MEDNAX's (MD) fourth-quarter results reflect muted revenues caused by the COVID-19 pandemic.
Community Health's (CYH) Q4 Earnings Surpass, Improve Y/Y
by Zacks Equity Research
Community Health's (CYH) fourth-quarter earnings gain from lower costs. However, the same is offset to some extent by soft admissions.
4 Hospital Stocks to Gain From Growth in Patient Admissions
by Sapna Bagaria
Players in the hospital industry are likely to gain from increasing patient admissions, government grants and cost-control measures.
Molina Healthcare (MOH) Posts Q4 Loss, Misses on Revenues
by Zacks Equity Research
Molina Healthcare's (MOH) fourth-quarter results reflect escalating expenses.
Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) Q4 earnings improve on the back of better revenues.
Centene (CNC) Q4 Earnings Surpass Estimates, Tumble Y/Y
by Zacks Equity Research
Centene (CNC) Q4 results gain from improved revenues as well as better membership.
The Zacks Analyst Blog Highlights: Sony, Mondelez International, Twilio, Workday and HCA Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Sony, Mondelez International, Twilio, Workday and HCA Healthcare
Q4 Earnings Scorecard and Analyst Reports for Sony, Mondelez & Twilio
by Sheraz Mian
We have provided a real-time update on the Q4 earnings season, in addition to featuring new research reports on 16 major stocks in today's Research Daily.
Ensign Group's (ENSG) Q4 Earnings Top Estimates, Improve Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) fourth-quarter results reflect a year-over-year rise in revenues.
Humana's (HUM) Q4 Loss Narrower Than Expected, Tumble Y/Y
by Zacks Equity Research
Humana's (HUM) fourth-quarter results reflect elevated costs related to COVID-19 along with high marketing expenses.
HCA Healthcare's (HCA) Q4 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings gain on the back of better revenues.
HCA Holdings (HCA) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 13.77% and 2.46%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for HCA Healthcare (HCA) Q4 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings are likely to have witnessed better patient volumes and improved revenues.
HCA Healthcare (HCA) Steps Up Efforts to Boost PPE Output
by Zacks Equity Research
HCA Healthcare (HCA) invests in new business to meet the buoyancy in demand for PPE and surgical masks.
Community Health (CYH) Unit Announces Junior Note Offerings
by Zacks Equity Research
Community Health's (CYH) wholly-owned arm exhibits monetary discretion by issuing notes to procure funds.
Here's Why You Should Hold MEDNAX (MD) in Your Portfolio Now
by Zacks Equity Research
Riding high on its strategic efforts and cost-cutting measures, MEDNAX (MD) holds enough potential to reap benefits for investors.
4 Sector ETFs & Stocks Top Despite Soft December Jobs Data
by Sanghamitra Saha
The U.S. jobs report for the month of December came in weaker than expected.
Here's Why You Should Bet on Acadia Healthcare (ACHC) Stock
by Zacks Equity Research
Acadia Healthcare (ACHC) has been benefiting from growing demand for behavioral health services, high revenues and solid cash flows.
Here's Why You Should Hold on to Universal Health (UHS) Now
by Zacks Equity Research
Rising high on solid segments and solvency levels, Universal Health (UHS) holds potential to reap benefits for investors.
Why Should You Retain HCA Healthcare (HCA) in Your Portfolio?
by Zacks Equity Research
Riding high on its growth efforts and cost-curbing initiatives, HCA Healthcare (HCA) holds potential to reap benefits for investors.